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1. Introduction 
Hemopexin, a /3-glycoprotein present in the plasma 
of mammals [l] , plays an important role in the 
disposal of plasma heme and has been implicated in 
the metabolism of other porphyrins [2]. The total 
number of residues in rabbit and human hemopexin 
(mol. wt approx. 57 500) is about 410 [3,4] and both 
proteins contain 20% carbohydrate [2,3]. Despite 
previous reports on the physicochemical properties of 
hemopexin and its interaction with porphyrins and 
heme [2,3,5,6], knowledge of its primary structure 
will be required to more fully appreciate. these inter- 
actions and to compare hemopexins derived from 
different species. 
This communication compares the peptide maps 
obtained from tryptic digests of human and rabbit 
hemopexin and their N-terminal amino acid sequences. 
The results indicate that a high degree of homology 
exists in the primary structure of the two hemopexin 
molecules. Moreover, preliminary evidence suggests 
the existence of genetic polymorphism in human 
hemopexin. 
2. Materials and methods 
Hemopexin was prepared from human and rabbit 
sera and its purity was estimated as previously describ- 
ed [3]. A limited amount of human hemerich 
hemopexin (Lot #689) was kindly donated by the 
Behringwerke A.G., Marburg, West Germany. Concen- 
trations of hemopexin solutions were determined 
employing an $to mm’ of 19.7 for the human and the 
rabbit protein [4]. 
North-Holland Publishing Company - Amsterdam 
Samples of hemopexin were reduced and carboxy- 
methylated [7] prior to digestion and in most cases 
prior to sequence analysis. Tryptic digests of lo-30 
mg hemopexin were performed at 1: 50 (w/w) ratios of 
trypsin (Worthington Lot #TCCA 6303) to hemopexin 
at 37°C in 2-4 ml water. The pH was maintained be- 
tween 7 and 9 by adding 0.3 N NH4 OH, and after 
90 min the solution was frozen and lyophilized. The 
dried material was dissolved in water to a concentra- 
tion of 50 mg/ml, and 50 fl was applied to Whatman 
No. 3 mm paper. Descending chromatography was 
performed in a mixture of set-butanol, formic acid, 
water (70:9:21) for 15 hr. After drying, electrophoresis 
was carried out in the second dimension at 2000 V in 
acetic acid:pyridine:HzO (10: 1:589) at pH 3.8 in a 
Savant apparatus. The peptide maps were stained with 
ninhydrin to locate peptides and with specific reagents 
to locate arginine- and histidine-containing peptides 
[8], and examined with ultraviolet light for tryptophan- 
containing fluorescent peptides. 
N-terminal sequences were determined with an 
updated Beckman Model 890A automatic sequencer 
using a dimethylallylamine buffer as previously describ- 
ed [9- 111. Identification of the phenylthiohydantoin- 
amino acid derivatives (PTH) was accomplished on a 
Beckman gas chromatograph [ 121 and in some cases 
by amino acid analysis after acid hydrolysis (6 N HCl , 
15O”C, 16 hr or 57% HI, 1 lO”C, 20 hr) of the PTH 
derivative. 
3. Results and Discussion 
The tryptic peptide maps of human and rabbit 
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Fig. 1. Tryptic peptide pattern of human hemopexin. Human hemopexin (Hx) was digested with trypsin and 2.5 mg applied to the 
chromatogram sheet as described in Materials and methods. The chromatogram was stained for peptides with ninhydrin (o) and 
examined for peptides which contained arginine (e), histidine (e), tyrosine (Q), and tryptophan (a). 
hemopexin are shown in figures 1 and 2. These 
patterns were repeatedly observed. As expected from 
the extreme sensitivity of tryptic peptide mapping to 
amino acid substitutions, few peptides seem identical 
to both proteins. However, similar peptides like those 
at B-9, C-4, D-2, D-7, E-5 appear in both proteins. 
These peptides may be derived from highly conserved 
areas of the protein presumably involved in the func- 
tion of hemopexin. 
The N-terminal sequences of human and rabbit 
hemopexin are aligned in table 1. The homology be; 
tween the two proteins in this small portion of the 
total primary structure is evident. Preliminary results 
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on the amino terminal sequence of rat hemopexin 
indicate that it more closely resembles rabbit hemopexin. 
Deletion of residues 5 and 6 was observed, but no N- 
terminal residue was identified. Sufficient amounts of 
highly purified rat hemopexin are presently not 
available for further analysis. 
The N-terminal residue of human hemopexin could 
not be unequivocally identified. Hydrolysis in HI of 
the PTH-amino acid released in the first step from 
human hemopexin resulted in a large alanine peak on 
amino acid analysis. In HI hydrolysis this could be 
either alanine, cysteine or serine. Our results would 
point to an N-terminal serine since neither PTH- 
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Fig. 2. Tryptic peptide pattern of rabbit hemopexin. Rabbit hemopexin (Hx) was digested with trypsin and 2.5 mg applied to the 
chromatogram sheet as described in Materials and methods. The chromatogram was stained for peptides with ninhydrin (0) and 
examined for peptides which contained arginine (e), histidine (Q), tyrosine (Q), and tryptophan (0). 
alanine nor F’TH-carboxymethylcysteine could be 
detected by gas chromatography or amino acid analysis, 
respectively. In a previous report, threonine was stated 
to be the N-terminal residue of human hemopexin (13). 
Hydrolysis in HI of PTH-threonine should yield CY- 
aminobutyric acid; this was not found by us. An 
explanation for this discrepancy must await further 
study of the primary structure. 
Evidence for genetic polymorphism in human 
hemopexin is shown in table 1 where two residues, 
leucine and phenylalanine, occur at position 3 of human 
hemopexin. The results obtained for the Behringwerke 
human hemopexin, which was isolated from pooled 
human sera, yielded nearly equal amounts of these 
amino acids. When human hemopexin isolated from 
separate donors was used, only leucine was obtained. 
No differences in the results were noted at any other 
position. A previous attempt by Stewart and Lovrein 
[ 141 to detect genetic polymorphism in human 
hemopexin by electrophoretic means was unsuccessful 
although polymorphism in rabbit and swine hemo- 
pexins have been reported [ 15,161. It is to be expect- 
ed that many, perhaps most, genetic variations are 
electrophoretically undetectable as in the case of 
human hemopexin and CY~ -acid glycoprotein [ 171. 
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